Clearline Capital LP

Holdings History for HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

Symbol: HRTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share
Latest Disclosed Shares Owned: 12,235,239 shares
Security Ownership %: 6.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Clearline Capital LP ownership in HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX)

17 Feb 2026 - Clearline Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,235,239 shares of HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX). This represents 6.7% ownership of the company. In their previous filing dated 26 Nov 2025, Clearline Capital LP had reported owning 9,712,527 shares, indicating an increase of +26%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Clearline Capital LP	6.7%	+28%	$18,108,154	12,235,239	+2,522,712	+26%	$1.48	13G/A	31 Dec 2025	17 Feb 2026, 14:40
Clearline Capital LP	5.3%		$11,655,032	9,712,527			$1.20	13G	30 Sep 2025	26 Nov 2025, 10:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.2%	+0.25%	$15,905,811	12,235,239	+2,522,712	+26%	$1.30	Q4 2025
30 Sep 2025	1.1%	+0.96%	$12,237,784	9,712,527	+8,855,361	+1033%	$1.26	Q3 2025
30 Jun 2025	0.16%	-0.04%	$1,774,334	857,166	-202,745	-19%	$2.07	Q2 2025
31 Mar 2025	0.24%	-0.17%	$2,331,804	1,059,911	-750,572		$2.20	Q1 2025
31 Dec 2024	0.37%	-0.08%	$2,770,039	1,810,483	-416,029	-19%	$1.53	Q4 2024
30 Sep 2024	0.39%	+0.13%	$4,430,759	2,226,512	+731,246	+49%	$1.99	Q3 2024
30 Jun 2024	0.46%	-0.44%	$5,233,431	1,495,266	-1,280,938	-46%	$3.50	Q2 2024
31 Mar 2024	0.76%	-0.9%	$7,690,085	2,776,204	-3,292,350	-54%	$2.77	Q1 2024
31 Dec 2023	1.2%	-0.02%	$10,316,542	6,068,554	-81,288	-1.3%	$1.70	Q4 2023
30 Sep 2023	0.63%	+0.36%	$6,334,338	6,149,842	+3,483,858	+131%	$1.03	Q3 2023
30 Jun 2023	0.4%	+0.09%	$3,092,542	2,665,984	+576,692	+28%	$1.16	Q2 2023
31 Mar 2023	0.48%	+0.24%	$3,154,831	2,089,292	+1,064,510	+104%	$1.51	Q1 2023
31 Dec 2022	0.46%	+0.46%	$2,561,956	1,024,782	+1,024,782	NEW	$2.50	Q4 2022
30 Jun 2020		-0.26%	$0	0	-47,667	-100%	$1.26	Q2 2020
31 Mar 2020	0.26%	+0.26%	$560,000	47,667	+47,667	NEW	$11.75	Q1 2020
30 Sep 2019		-0.15%	$0	0	-16,920	-100%	$1.26	Q3 2019
30 Jun 2019	0.15%	-0.2%	$315,000	16,920	-22,416	-57%	$18.62	Q2 2019
31 Mar 2019	0.5%	0%	$961,000	39,336	0		$24.43	Q1 2019
31 Dec 2018	0.7%	+0.15%	$1,020,000	39,336	+8,577	+28%	$25.93	Q4 2018
30 Sep 2018	0.58%	+0.58%	$974,000	30,759	+30,759	NEW	$31.67	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.